长期COVID患者严重ARDS的结果,后续和呼吸系统策略:一个回顾性队列研究
Diana-Alexandra Mîțu1, Florina Buleu2,3, Daian-Ionel Popa1,3,4
1Doctoral School, Faculty of General Medicine, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Journal of clinical medicine
|October 29, 2025
概括
患有长期COVID和严重ARDS的患者面临极高的死亡率. 连续正气道压力 (CPAP) 与输管前高流量鼻腔管 (HFNC) 相比,显示出改善生存的趋势.
科学领域:
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
- 关键护理医学 关键护理医学
背景情况:
- 在长期COVID患者中,严重急性呼吸困扰综合征 (ARDS) 具有较高的死亡率和后果.
- 非侵入性通风 (NIV) 如CPAP和HFNC在内内输管 (ETI) 之前使用.
- 在这个人群中,NIV策略的比较有效性尚未得到充分证实.
研究的目的:
- 评估长期COVID患者的结局,后果和治疗策略,这些患者患有严重的ARDS.
- 在ETI之前,专注于非侵入性呼吸系统支持的有效性.
- 为这个高风险群体完善治疗策略.
主要方法:
- 追溯队列分析,比较患有和没有COVID-19的严重ARDS患者.
- 纳入标准:PaO2/FiO2比率小于50毫米平.
- 基于初始NIV策略 (CPAP,HFNC或两者) 的结果分析.
主要成果:
- 在59名长期COVID ARDS患者中85%的死亡率.
- 与HFNC或交替策略相比,CPAP组的生存率较高 (23.08%).
- 输管后的存活率各不相同:40% (之前的CPAP),10% (交替),0% (只有HFNC).
- 幸存者经历了后续症状:肺功能受损,呼吸不全,体力表现下降.
结论:
- 长期COVID严重ARDS患者面临异常高的ICU死亡率.
- 结局受到年龄,并发症和低氧化血症的影响.
- CPAP趋向于改善生存率,但需要更大的研究来确认.
- 突出了这个子组的复杂性和进一步研究的需要.
相关概念视频
Pneumonia III: Complications and Assessment
775
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
775
Acute Respiratory Failure-V
448
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
448
Acute Respiratory Failure-II
1.0K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.0K
Pneumonia IV: Management
749
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
749
COPD: Management Using Bronchodilators and Corticosteroids
719
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
719
Acute Respiratory Failure-III
761
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
761

